Literature DB >> 5549411

Effects of L-dopa on efflux of cerebral monoamines from synaptosomes.

K Y Ng, R W Colburn, I J Kopin.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5549411     DOI: 10.1038/230331a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  11 in total

Review 1.  Mechanisms underlying the onset and expression of levodopa-induced dyskinesia and their pharmacological manipulation.

Authors:  Mahmoud M Iravani; Peter Jenner
Journal:  J Neural Transm (Vienna)       Date:  2011-09-01       Impact factor: 3.575

Review 2.  Molecular imaging of levodopa-induced dyskinesias.

Authors:  Flavia Niccolini; Lorenzo Rocchi; Marios Politis
Journal:  Cell Mol Life Sci       Date:  2015-02-15       Impact factor: 9.261

3.  L-DOPA sensitizes vasomotor tone by modulating the vascular alpha1-adrenergic receptor.

Authors:  Daiki Masukawa; Motokazu Koga; Anna Sezaki; Yuka Nakao; Yuji Kamikubo; Tatsuo Hashimoto; Yuki Okuyama-Oki; Aderemi Caleb Aladeokin; Fumio Nakamura; Utako Yokoyama; Hiromichi Wakui; Hiroshi Ichinose; Takashi Sakurai; Satoshi Umemura; Koichi Tamura; Yoshihiro Ishikawa; Yoshio Goshima
Journal:  JCI Insight       Date:  2017-09-21

4.  Influence of repeated levodopa administration on rabbit striatal serotonin metabolism, and comparison between striatal and CSF alterations.

Authors:  D A Loeffler; P A LeWitt; P L Juneau; D M Camp; A J DeMaggio; M K Havaich; P E Milbury; W R Matson
Journal:  Neurochem Res       Date:  1998-12       Impact factor: 3.996

5.  Targeted manipulation of serotonergic neurotransmission affects the escalation of aggression in adult male Drosophila melanogaster.

Authors:  Olga V Alekseyenko; Carol Lee; Edward A Kravitz
Journal:  PLoS One       Date:  2010-05-24       Impact factor: 3.240

6.  Local administration of sarizotan into the subthalamic nucleus attenuates levodopa-induced dyskinesias in 6-OHDA-lesioned rats.

Authors:  C Marin; E Aguilar; M C Rodríguez-Oroz; G D Bartoszyk; J A Obeso
Journal:  Psychopharmacology (Berl)       Date:  2009-01-22       Impact factor: 4.530

7.  Eltoprazine counteracts l-DOPA-induced dyskinesias in Parkinson's disease: a dose-finding study.

Authors:  Per Svenningsson; Carl Rosenblad; Karolina Af Edholm Arvidsson; Klas Wictorin; Charlotte Keywood; Bavani Shankar; David A Lowe; Anders Björklund; Håkan Widner
Journal:  Brain       Date:  2015-02-10       Impact factor: 13.501

Review 8.  What Mechanisms Are Responsible for the Reuptake of Levodopa-Derived Dopamine in Parkinsonian Striatum?

Authors:  Haruo Nishijima; Masahiko Tomiyama
Journal:  Front Neurosci       Date:  2016-12-15       Impact factor: 4.677

9.  Serotonergic mechanisms responsible for levodopa-induced dyskinesias in Parkinson's disease patients.

Authors:  Marios Politis; Kit Wu; Clare Loane; David J Brooks; Lorenzo Kiferle; Federico E Turkheimer; Peter Bain; Sophie Molloy; Paola Piccini
Journal:  J Clin Invest       Date:  2014-02-17       Impact factor: 14.808

10.  SERT-to-DAT ratios in early Parkinson's disease do not correlate with the development of dyskinesias.

Authors:  Sven R Suwijn; Henk W Berendse; Constant Vm Verschuur; Ania Winogrodzka; Rob Ma de Bie; Jan Booij
Journal:  EJNMMI Res       Date:  2013-06-05       Impact factor: 3.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.